These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7961023)

  • 1. The in vivo interaction between vincristine and radiation in a C3H mammary carcinoma and the feet of CDF1 mice.
    Grau C; Høyer M; Overgaard J
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1141-6. PubMed ID: 7961023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vivo response of a C3H mammary carcinoma to treatment with misonidazole, cyclophosphamide and radiation.
    Grau C; Zachariae C; Mao HS; Overgaard J
    Acta Oncol; 1990; 29(6):769-74. PubMed ID: 2223148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
    Grau C; Overgaard J
    Cancer Chemother Pharmacol; 1992; 30(4):277-80. PubMed ID: 1643695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumour effect of photodynamic therapy by microtubule inhibitors.
    Ma LW; Berg K; Danielsen HE; Kaalhus O; Iani V; Moan J
    Cancer Lett; 1996 Dec; 109(1-2):129-39. PubMed ID: 9020912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
    Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
    Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of misonidazole, hyperthermia, and irradiation in a C3H mammary carcinoma and its surrounding skin in vivo.
    Mao HS; Grau C; Overgaard J
    Int J Radiat Oncol Biol Phys; 1992; 22(1):115-22. PubMed ID: 1727107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R; Tsujitani M; Horsman MR
    Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
    Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
    Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors.
    Murata R; Siemann DW; Overgaard J; Horsman MR
    Radiother Oncol; 2001 Aug; 60(2):155-61. PubMed ID: 11439210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Horsman MR
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of step-down heating on hyperthermic radiosensitization in an experimental tumor and a normal tissue in vivo.
    Lindegaard JC; Overgaard J
    Radiother Oncol; 1988 Feb; 11(2):143-51. PubMed ID: 3353518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response.
    Horsman MR; Murata R
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1047-55. PubMed ID: 14575836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
    Overgaard J; Radacic MM; Grau C
    Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel enhances tumor radioresponse in vivo.
    Mason KA; Hunter NR; Milas M; Abbruzzese JL; Milas L
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2431-8. PubMed ID: 9815644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative investigations on the effect of different dose schedules of the phase-specific drug vincristine (VCR) on the proliferation kinetics of a solid experimental tumour.
    Féaux de Lacroix W; Mallmann H
    Cell Tissue Kinet; 1984 Nov; 17(6):583-91. PubMed ID: 6488276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of radiation, cyclophosphamide and nimorazole in a C3H mammary carcinoma in vivo.
    Zachariae C; Overgaard J
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1445-8. PubMed ID: 3759571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms underlying reduced growth rate in C3HBA mammary adenocarcinomas recurring after single doses of x-rays or fast neutrons.
    Nelson JS; Carpenter RE; Durboraw D
    Cancer Res; 1976 Feb; 36(2 Pt 1):524-31. PubMed ID: 1260751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment.
    Overgaard J; Radacic M; Skaric D; Skaric V; Horsman MR; Lindegaard JC; Jercic J
    Int J Hyperthermia; 1993; 9(6):821-30. PubMed ID: 8106823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effects of vincristine on tumour subpopulations separated from pulmonary nodules.
    Grdina DJ; White RA; Stragand JJ
    Br J Cancer; 1983 Aug; 48(2):279-87. PubMed ID: 6882666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2).
    Jürgenliemk-Schulz IM; Renes IB; Rutgers DH; Everse LA; Bernsen MR; Den Otter W; Battermann JJ
    Radiat Oncol Investig; 1997; 5(2):54-61. PubMed ID: 9303058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.